WO1999038864A1 - Oxazole derivatives as serotonin-1a receptor agonists - Google Patents
Oxazole derivatives as serotonin-1a receptor agonists Download PDFInfo
- Publication number
- WO1999038864A1 WO1999038864A1 PCT/US1999/002210 US9902210W WO9938864A1 WO 1999038864 A1 WO1999038864 A1 WO 1999038864A1 US 9902210 W US9902210 W US 9902210W WO 9938864 A1 WO9938864 A1 WO 9938864A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carbon atoms
- alkyl
- compound
- aryl
- arylalkyl
- Prior art date
Links
- 0 *1c2ccccc2C2C1CNCC2 Chemical compound *1c2ccccc2C2C1CNCC2 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99905632A EP1053235A1 (en) | 1998-02-03 | 1999-02-02 | Oxazole derivatives as serotonin-1a receptor agonists |
CA002317515A CA2317515A1 (en) | 1998-02-03 | 1999-02-02 | Oxazole derivatives as serotonin-1a receptor agonists |
AU25753/99A AU2575399A (en) | 1998-02-03 | 1999-02-02 | Oxazole derivatives as serotonin-1a receptor agonists |
JP2000529332A JP2002501920A (en) | 1998-02-03 | 1999-02-02 | Oxazole derivatives as serotonin-1A receptor agonists |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1751798A | 1998-02-03 | 1998-02-03 | |
US09/017,517 | 1998-02-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999038864A1 true WO1999038864A1 (en) | 1999-08-05 |
Family
ID=21783033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/002210 WO1999038864A1 (en) | 1998-02-03 | 1999-02-02 | Oxazole derivatives as serotonin-1a receptor agonists |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1053235A1 (en) |
JP (1) | JP2002501920A (en) |
CN (1) | CN1289333A (en) |
AU (1) | AU2575399A (en) |
CA (1) | CA2317515A1 (en) |
WO (1) | WO1999038864A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6242448B1 (en) * | 1998-12-17 | 2001-06-05 | American Home Products Corporation | Trisubstituted-oxazole derivatives as serotonin ligands |
WO2002060423A2 (en) * | 2001-01-29 | 2002-08-08 | Otsuka Pharmaceutical Co., Ltd. | Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
US7053092B2 (en) | 2001-01-29 | 2006-05-30 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1a receptor subtype agonist |
EP1855679A2 (en) * | 2005-01-19 | 2007-11-21 | Merck & Co., Inc. | Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease |
US7910589B2 (en) | 2001-09-25 | 2011-03-22 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
US8106074B2 (en) | 2001-07-13 | 2012-01-31 | Pierre Fabre Medicament | Pyridin-2-yl-methylamine derivatives for treating opiate dependence |
US8703772B2 (en) | 2001-09-25 | 2014-04-22 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0516313D0 (en) * | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
CA2931219A1 (en) * | 2013-12-20 | 2015-06-25 | Laboratorios Del Dr. Esteve, S.A. | Piperidine compounds having multimodal activity against pain |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0356098A2 (en) * | 1988-08-15 | 1990-02-28 | Glaxo Group Limited | Lactam derivatives |
US5162322A (en) * | 1991-03-06 | 1992-11-10 | A. H. Robbins Company, Incorporated | Method of treating anxiety with 5-[(4-aryl or heteroaryl-1-piperazinyl]alkyl)-2-oxazolidinones |
-
1999
- 1999-02-02 CA CA002317515A patent/CA2317515A1/en not_active Abandoned
- 1999-02-02 EP EP99905632A patent/EP1053235A1/en not_active Withdrawn
- 1999-02-02 CN CN99802651A patent/CN1289333A/en active Pending
- 1999-02-02 AU AU25753/99A patent/AU2575399A/en not_active Abandoned
- 1999-02-02 WO PCT/US1999/002210 patent/WO1999038864A1/en not_active Application Discontinuation
- 1999-02-02 JP JP2000529332A patent/JP2002501920A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0356098A2 (en) * | 1988-08-15 | 1990-02-28 | Glaxo Group Limited | Lactam derivatives |
US5162322A (en) * | 1991-03-06 | 1992-11-10 | A. H. Robbins Company, Incorporated | Method of treating anxiety with 5-[(4-aryl or heteroaryl-1-piperazinyl]alkyl)-2-oxazolidinones |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6242448B1 (en) * | 1998-12-17 | 2001-06-05 | American Home Products Corporation | Trisubstituted-oxazole derivatives as serotonin ligands |
EP1621198A3 (en) * | 2001-01-29 | 2006-04-12 | Otsuka Pharmaceutical Co., Ltd. | Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists |
US7053092B2 (en) | 2001-01-29 | 2006-05-30 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1a receptor subtype agonist |
US9089567B2 (en) | 2001-01-29 | 2015-07-28 | Otsuka Pharmaceutical Co., Ltd. | Method of treating cognitive impairments and schizophrenias |
US8680105B2 (en) | 2001-01-29 | 2014-03-25 | Otsuka Pharmaceutical Co., Ltd. | Method of treating down's syndrome |
US8030312B2 (en) | 2001-01-29 | 2011-10-04 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1A receptor subtype agonist |
EP1712225A1 (en) * | 2001-01-29 | 2006-10-18 | Otsuka Pharmaceutical Co., Ltd. | Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists |
US9387207B2 (en) | 2001-01-29 | 2016-07-12 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1A receptor subtype agonist |
US8642600B2 (en) | 2001-01-29 | 2014-02-04 | Otsuka Pharmaceutical Co., Ltd. | Method of treating autism |
EP1621198A2 (en) * | 2001-01-29 | 2006-02-01 | Otsuka Pharmaceutical Co., Ltd. | Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists |
WO2002060423A3 (en) * | 2001-01-29 | 2003-04-10 | Otsuka Pharma Co Ltd | Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
WO2002060423A2 (en) * | 2001-01-29 | 2002-08-08 | Otsuka Pharmaceutical Co., Ltd. | Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
US9006248B2 (en) | 2001-01-29 | 2015-04-14 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1A receptor subtype agonist |
US8426423B2 (en) | 2001-01-29 | 2013-04-23 | Otsuka Pharmaceutical Co., Ltd. | Method of treating Attention Deficit Hyper-Activity Disorder |
US8722680B2 (en) | 2001-01-29 | 2014-05-13 | Otsuka Pharmaceutical Co., Ltd. | Method of treating neurodegenerative diseases |
US8604041B2 (en) | 2001-01-29 | 2013-12-10 | Otsuka Pharmaceutical Co., Ltd. | Method of treating panic disorder |
US8623874B2 (en) | 2001-01-29 | 2014-01-07 | Otsuka Pharmaceutical Co., Ltd. | Method of treating neurodegenerative diseases |
US8106074B2 (en) | 2001-07-13 | 2012-01-31 | Pierre Fabre Medicament | Pyridin-2-yl-methylamine derivatives for treating opiate dependence |
US7910589B2 (en) | 2001-09-25 | 2011-03-22 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
US8901130B2 (en) | 2001-09-25 | 2014-12-02 | Ostuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation |
US8703772B2 (en) | 2001-09-25 | 2014-04-22 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
US8703773B2 (en) | 2001-09-25 | 2014-04-22 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
US8580796B2 (en) | 2001-09-25 | 2013-11-12 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
US10150735B2 (en) | 2001-09-25 | 2018-12-11 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
US8901303B2 (en) | 2001-09-25 | 2014-12-02 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
US8642760B2 (en) | 2001-09-25 | 2014-02-04 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
US8993761B2 (en) | 2001-09-25 | 2015-03-31 | Otsuka Pharamceutical Co. Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
US8399469B2 (en) | 2001-09-25 | 2013-03-19 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
US8017615B2 (en) | 2001-09-25 | 2011-09-13 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
US9359302B2 (en) | 2001-09-25 | 2016-06-07 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
EP1855679A2 (en) * | 2005-01-19 | 2007-11-21 | Merck & Co., Inc. | Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease |
EP1855679A4 (en) * | 2005-01-19 | 2014-07-23 | Merck Sharp & Dohme | Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease |
Also Published As
Publication number | Publication date |
---|---|
EP1053235A1 (en) | 2000-11-22 |
CN1289333A (en) | 2001-03-28 |
CA2317515A1 (en) | 1999-08-05 |
AU2575399A (en) | 1999-08-16 |
JP2002501920A (en) | 2002-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5466689A (en) | Morpholine derivatives and their use | |
US5929089A (en) | 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one derivatives for use as 5-Ht4 or H3 receptor ligands | |
JP3294961B2 (en) | Novel imidazole derivative and method for producing the same | |
PL116532B1 (en) | Process for preparing novel derivatives of amides of 2-methoxy-4-amino-5-alkylsulfonylbenzoic acid | |
WO2007129111A1 (en) | Diazepine derivatives as 5-ht2a antagonists | |
JPH054983A (en) | Isoquinolinone derivative, its production and 5-ht3 receptor antagonist containing the derivative as active component | |
EP0319429B1 (en) | 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient | |
JPH0283375A (en) | 2-substituted piperazinyl-2-(1,2-benzisoxazol-3-yl)acetic acid derivative | |
JP2001512727A (en) | Bicyclic compounds as ligands for the 5HT-1 receptor | |
AU704388B2 (en) | N-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl)benzamide derivatives, their preparation and their application in therapeutics | |
AU7935298A (en) | Novel naphthyridine derivatives or salts thereof | |
WO1999038864A1 (en) | Oxazole derivatives as serotonin-1a receptor agonists | |
RU2162470C2 (en) | 2,7-substituted derivatives of octahydropyrrolo[1,2-a]pyrazine, method of treatment, pharmaceutical composition, and intermediates | |
JPH10504820A (en) | Use of N-substituted phenothiazines | |
JPH04225986A (en) | Novel pyrido (2,3-f) (1,4) thiazepine and pyrido (3,2-b) (1,5) benzothiazepine | |
JPH02138266A (en) | 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidine dione derivative | |
SK74199A3 (en) | 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application | |
WO1999054303A1 (en) | Optically active tetrahydrobenzindole derivatives | |
US5446050A (en) | Azabicyclo amides and esters as 5-HT3 receptor antagonists | |
US5519025A (en) | 4-indolylpiperazinyl derivatives | |
US6242448B1 (en) | Trisubstituted-oxazole derivatives as serotonin ligands | |
US6057340A (en) | Oxazole derivatives as serotonin-1A receptor agonists | |
HUT54151A (en) | Process fopr producing new (r)-(-)-3-quinuclidinone derivatives and pharmaceutical compositions comprising such compounds | |
IE903616A1 (en) | Neuroprotectant Agents | |
JPH07258250A (en) | Ester derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99802651.4 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2317515 Country of ref document: CA Ref document number: 2317515 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999905632 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2000 529332 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1999905632 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999905632 Country of ref document: EP |